Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fumonisin B1 is the most abundant and toxic fumonisin and is a mycotoxin produced from Fusarium moniliforme. Fumonisin B1 is also a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 183.00 | |
5 mg | 35 days | $ 793.00 | |
10 mg | 35 days | $ 1,340.00 |
Description | Fumonisin B1 is the most abundant and toxic fumonisin and is a mycotoxin produced from Fusarium moniliforme. Fumonisin B1 is also a potent inhibitor of sphingosine N-acyltransferase (ceramide synthase) and disrupts de novo sphingolipid biosynthesis. |
In vitro | Fumonisin B1 changes the gene expression and signal transduction pathways in monkey kidney cells. Fumonisin B1 increases the initial disruption of sphingolipid metabolism and the accumulation of sphinganine in LLC-PK1 kidney cells. Which causes DNA damage of apoptotic type in rat astrocytes [3]. |
Molecular Weight | 721.83 |
Formula | C34H59NO15 |
CAS No. | 116355-83-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Methanol: 10 mg/mL (13.85 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fumonisin B1 116355-83-0 Others Fumonisin B-1 inhibitor inhibit